POT1 variants were subsequently observed in 10% of sporadic CAS (n = 1/10), and 10% of sporadic cardiac sarcoma (n = 2/20), while 20% of LFL families with members who suffered from angiosarcoma had a POT1 germline mutation (n = 2/10) [94]. This evidence concerns the gene POT1 and angiosarcoma.